OppenheimerFunds’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

OppenheimerFunds’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$228K	Sell	2,000 -423,690	-100%	-$31.1M	﹤0.01%	1667
2018 Q4	$16.7M	Sell	425,690 -760	-0.2%	-$33K	0.02%	556
2018 Q3	$23.3M	Sell	426,450 -90	-0%	-$6.16K	0.03%	551
2018 Q2	$35.3M	Buy	426,540 +455	+0.1%	+$35.1K	0.04%	421
2018 Q1	$28.4M	Buy	426,085 +207,316	+95%	+$12M	0.04%	470
2017 Q4	$11.2M	Buy	+218,769	New	+$15.7M	0.01%	722

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

OppenheimerFunds's ONCE Position: Q1 2019 in Review

OppenheimerFunds reduced its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 100% in Q1 2019, selling an estimated $31.1M and leaving 2,000 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

OppenheimerFunds first reported a position in ONCE in Q4 2017 and has held it in 6 quarters since. The position peaked at $35.3M in Q2 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

OppenheimerFunds held 2,000 shares of Spark Therapeutics, Inc. Common Stock worth $228K as of Q1 2019.
OppenheimerFunds sold 423,690 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $31.1M.
Spark Therapeutics, Inc. Common Stock made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1667 holding.
OppenheimerFunds first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and has held it in 6 quarters since.
OppenheimerFunds's Spark Therapeutics, Inc. Common Stock position peaked at $35.3M in Q2 2018.
199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.